These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27270277)

  • 1. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
    Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation.
    Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ
    mBio; 2020 Jan; 11(1):. PubMed ID: 31992618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potent antimalarial benzoxaborole targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue.
    Sonoiki E; Ng CL; Lee MC; Guo D; Zhang YK; Zhou Y; Alley MR; Ahyong V; Sanz LM; Lafuente-Monasterio MJ; Dong C; Schupp PG; Gut J; Legac J; Cooper RA; Gamo FJ; DeRisi J; Freund YR; Fidock DA; Rosenthal PJ
    Nat Commun; 2017 Mar; 8():14574. PubMed ID: 28262680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptosporidium and Toxoplasma Parasites Are Inhibited by a Benzoxaborole Targeting Leucyl-tRNA Synthetase.
    Palencia A; Liu RJ; Lukarska M; Gut J; Bougdour A; Touquet B; Wang ED; Li X; Alley MR; Freund YR; Rosenthal PJ; Hakimi MA; Cusack S
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5817-27. PubMed ID: 27431220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
    Deniskin R; Frame IJ; Sosa Y; Akabas MH
    Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzoxaborole antimalarial agents. Part 4. Discovery of potent 6-(2-(alkoxycarbonyl)pyrazinyl-5-oxy)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Sanders V; Freund YR; Campo B; Rosenthal PJ; Bu W; Gamo FJ; Sanz LM; Ge M; Li L; Ding J; Yang Y
    J Med Chem; 2015 Jul; 58(13):5344-54. PubMed ID: 26067904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzoxaborole Antimalarial Agents. Part 5. Lead Optimization of Novel Amide Pyrazinyloxy Benzoxaboroles and Identification of a Preclinical Candidate.
    Zhang YK; Plattner JJ; Easom EE; Jacobs RT; Guo D; Freund YR; Berry P; Ciaravino V; Erve JCL; Rosenthal PJ; Campo B; Gamo FJ; Sanz LM; Cao J
    J Med Chem; 2017 Jul; 60(13):5889-5908. PubMed ID: 28635296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and structure-activity relationships of novel benzoxaboroles as a new class of antimalarial agents.
    Zhang YK; Plattner JJ; Freund YR; Easom EE; Zhou Y; Gut J; Rosenthal PJ; Waterson D; Gamo FJ; Angulo-Barturen I; Ge M; Li Z; Li L; Jian Y; Cui H; Wang H; Yang J
    Bioorg Med Chem Lett; 2011 Jan; 21(2):644-51. PubMed ID: 21195617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of antimalarial drug action by chlorpheniramine against multidrug-resistant Plasmodium falciparum in vitro.
    Nakornchai S; Konthiang P
    Parasitol Int; 2006 Sep; 55(3):195-9. PubMed ID: 16750932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystal structures of the human and fungal cytosolic Leucyl-tRNA synthetase editing domains: A structural basis for the rational design of antifungal benzoxaboroles.
    Seiradake E; Mao W; Hernandez V; Baker SJ; Plattner JJ; Alley MR; Cusack S
    J Mol Biol; 2009 Jul; 390(2):196-207. PubMed ID: 19426743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective activity of biflavanones from Garcinia kola against Plasmodium infection.
    Konziase B
    J Ethnopharmacol; 2015 Aug; 172():214-8. PubMed ID: 26129936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and Molecular Surveillance for Antimalarial Drug Resistance in Plasmodium falciparum Parasites in Western Kenya Reveals Sustained Artemisinin Sensitivity and Increased Chloroquine Sensitivity.
    Lucchi NW; Komino F; Okoth SA; Goldman I; Onyona P; Wiegand RE; Juma E; Shi YP; Barnwell JW; Udhayakumar V; Kariuki S
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7540-7. PubMed ID: 26392510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3,5-bis(benzylidene)-4-piperidones and related N-acyl analogs: a novel cluster of antimalarials targeting the liver stage of Plasmodium falciparum.
    Das U; Singh RS; Alcorn J; Hickman MR; Sciotti RJ; Leed SE; Lee PJ; Roncal N; Dimmock JR
    Bioorg Med Chem; 2013 Dec; 21(23):7250-6. PubMed ID: 24139941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes.
    Magistrado PA; Corey VC; Lukens AK; LaMonte G; Sasaki E; Meister S; Wree M; Winzeler E; Wirth DF
    ACS Infect Dis; 2016 Nov; 2(11):816-826. PubMed ID: 27933786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimalarial pantothenamide metabolites target acetyl-coenzyme A biosynthesis in
    Schalkwijk J; Allman EL; Jansen PAM; de Vries LE; Verhoef JMJ; Jackowski S; Botman PNM; Beuckens-Schortinghuis CA; Koolen KMJ; Bolscher JM; Vos MW; Miller K; Reeves SA; Pett H; Trevitt G; Wittlin S; Scheurer C; Sax S; Fischli C; Angulo-Barturen I; Jiménez-Diaz MB; Josling G; Kooij TWA; Bonnert R; Campo B; Blaauw RH; Rutjes FPJT; Sauerwein RW; Llinás M; Hermkens PHH; Dechering KJ
    Sci Transl Med; 2019 Sep; 11(510):. PubMed ID: 31534021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo activity of Proveblue, a methylene blue, against field isolates of Plasmodium falciparum in Dakar, Senegal from 2013-2015.
    Fall B; Madamet M; Diawara S; Briolant S; Wade KA; Lo G; Nakoulima A; Fall M; Bercion R; Kounta MB; Amalvict R; Benoit N; Gueye MW; Diatta B; Wade B; Pradines B
    Int J Antimicrob Agents; 2017 Aug; 50(2):155-158. PubMed ID: 28689867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains.
    Chugh M; Scheurer C; Sax S; Bilsland E; van Schalkwyk DA; Wicht KJ; Hofmann N; Sharma A; Bashyam S; Singh S; Oliver SG; Egan TJ; Malhotra P; Sutherland CJ; Beck HP; Wittlin S; Spangenberg T; Ding XC
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1110-8. PubMed ID: 25487796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transfer editing by a eukaryotic leucyl-tRNA synthetase resistant to the broad-spectrum drug AN2690.
    Zhou XL; Tan M; Wang M; Chen X; Wang ED
    Biochem J; 2010 Sep; 430(2):325-33. PubMed ID: 20557293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE EFFICACY OF MARINE NATURAL PRODUCTS AGAINST PLASMODIUM FALCIPARUM.
    Goto Y; Kamihira R; Nakao Y; Nonaka M; Takano R; Xuan X; Kato K
    J Parasitol; 2021 Mar; 107(2):284-288. PubMed ID: 33844839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro Sensitivity of Pyronaridine in Thai Isolates of
    Mahotorn K; Tan-Ariya P; Thita T; Ruang-Areerate T; Sittichot N; Suwandittakul N; Mungthin M
    Am J Trop Med Hyg; 2018 Jan; 98(1):51-56. PubMed ID: 29141758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.